WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced the launch of the new LabChip® GX Touch and GXII ...
HOPKINTON, Mass., Nov. 2 Caliper Life Sciences, Inc. (Nasdaq: CALP), a leading provider of life sciences tools, today announced the availability of two new products that expand the LabChip GX product ...
Firms will also develop specific diagnostic identification, scoring, and reporting software for future LabChip Dx instruments. Caliper Life Sciences and DxTerity Diagnostics entered into a ...
Caliper's LabChip instruments -- the LabChip 3000 and LabChip EZ Reader (R) series -- which have been adopted by 17 of the top 20 pharmaceutical and biotechnology companies, utilize proprietary ...
Caliper Life Sciences, Inc. has announced expanded sales of its LabChip ® 3000 drug discovery system with top tier customers including AstraZeneca, Novartis and Vertex Pharmaceuticals. The LabChip ...
Making its latest foray into the microfluidics ring, Hopkinton, Mass.-based Caliper Life Sciences https://www.caliperls.com has introduced the new LabChip 3000 Drug Discovery System, a ...
PerkinElmer, Inc has announced the launch of its new LabChip® NGS 3K assay for genomics research. Using PerkinElmer’s LabChip platform and the NGS 3K assay, researchers will be able to quantitate DNA ...
Caliper Life Sciences, Inc announced a co-marketing agreement with Illumina, Inc for Caliper’s LabChip XT library preparation instrument and its LabChip GX analytical quality control platform. These ...
The LabChip® system will be designed to enable a researcher on earth to set up experimental conditions in space, directly observe and analyze the crystals, and then identify desired changes to the ...
The Massey Genome Service (MGS) is now offering our LabChip® Service for the quality and quantification assessment of DNA and RNA samples. It is a very valuable tool for assessing the quality of your ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results